International – How Can Nanotechnologies Aid Implantable Drug-Delivery Systems?

An industry expert shares how emerging micro and nanotechnologies could shape the next generation of implantable drug-delivery systems.

Implantable technologies have come a long way over the years, and advancements in micro and nanotechnologies have helped device developers continue to push the envelope even further. Within the realm of drug delivery, advances in nanotechnologies have consistently improved patient outcomes by enabling sustained drug delivery to help treat chronic conditions. These scalable technologies have even offered localized drug delivery that can further improve bioavailability.

While many of these technologies offer a variety of opportunities, we’re still eagerly awaiting to see the impact of these advancements once they’re actually leveraged against implantable device technologies. Many believe that recent micro and nanotechnology advancements could pave the way for things like increased local administration of drugs, zero-order release kinetics, more efficacious use of existing drugs with great bioavailability, personalized poly-pharmacy, and even on-demand drug delivery.

To better understand some of these potential outcomes, MD+DI checked in with Murty Vyakarnam, PhD, an innovator in medical devices, drug-device combination products, and biomaterials. He previously served as head of Global R&D for medical devices and pharma solutions for the newly created Lubrizol Lifesciences business unit, a Berkshire Hathaway company. He’s also spent time as director of research and development for Advanced Technologies & Regenerative Medicine…